Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Devisscher, Lindsey" or (type any "bookEditor issueEditor" and editor="Devisscher, Lindsey")

Add to list
- Journal Article
- open access
Rodent models of cholestatic liver disease: A practical guide for translational research

Eva Gijbels (UGent) , Alanah Pieters, Kevin De Muynck (UGent) , Mathieu Vinken and Lindsey Devisscher (UGent)

(2021) Liver International.
Add to list
- Journal Article
- open access
NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma

Astrid Vandierendonck (UGent) , Helena Degroote (UGent) , Bart Vanderborght (UGent) , Xavier Verhelst (UGent) , Anja Geerts (UGent) , Lindsey Devisscher (UGent) and Hans Van Vlierberghe (UGent)

(2021) Journal of Experimental & Clinical Cancer Research.
Add to list
- Journal Article
- A2
- open access
Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model

Eva Gijbels, Lindsey Devisscher (UGent) and Mathieu Vinken

(2020) DATA IN BRIEF. 32.
Add to list
- Journal Article
- A1
- open access
The angiopoietin/tie2 pathway in hepatocellular carcinoma

Bart Vanderborght (UGent) , Sander Lefere (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2020) CELLS. 9(11).
Add to list
Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Eva Gijbels, Vânia Vilas‐Boas, Pieter Annaert, Tamara Vanhaecke, Lindsey Devisscher (UGent) and Mathieu Vinken

(2020) ARCHIVES OF TOXICOLOGY. 94(4). p.1151-1172
Add to list
- Journal Article
- A2
- open access
Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease

Sanne Van Campenhout (UGent) , Agustina Ari Murti Budi Hastuti (UGent) , Sander Lefere (UGent) , Hans Van Vlierberghe (UGent) , Frank Vanhaecke (UGent) , Marta Costas Rodriguez (UGent) and Lindsey Devisscher (UGent)

(2020) BMC RESEARCH NOTES. 13.
Add to list
- Journal Article
- open access
Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model

Bart Vanderborght (UGent) , Kevin De Muynck (UGent) , Sander Lefere (UGent) , Anja Geerts (UGent) , Helena Degroote (UGent) , Xavier Verhelst (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2020) Oncotarget. p.4504-4520
Add to list
Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury

Sarah Raevens, Sanne Van Campenhout (UGent) , Pieter-Jan Debacker, Sander Lefere (UGent) , Xavier Verhelst (UGent) , Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) , Isabelle Colle (UGent) and Lindsey Devisscher (UGent)

(2020) JOURNAL OF LEUKOCYTE BIOLOGY. 107(2). p.341-355
Add to list
Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model

Sanne Van Campenhout (UGent) , Laurentijn Tilleman (UGent) , Sander Lefere (UGent) , Astrid Vandierendonck (UGent) , Sarah Raevens, Xavier Verhelst (UGent) , Anja Geerts (UGent) , Filip Van Nieuwerburgh (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2020) METABOLISM-CLINICAL AND EXPERIMENTAL. 107.
Add to list
- Journal Article
Myeloid -specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model

Sanne Van Campenhout (UGent) , Laurentijn Tilleman, Sander Lefere (UGent) , Astrid Vandierendonck (UGent) , Sarah Raevens, Xavier Verhelst (UGent) , Anja Geerts (UGent) , Filip Van Nieuwerburgh, Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2020) METABOLISM-CLINICAL AND EXPERIMENTAL. 107.

Academic Bibliography

Rodent models of cholestatic liver disease: A practical guide for translational research

NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma

Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model

The angiopoietin/tie2 pathway in hepatocellular carcinoma

Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease

Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model

Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury

Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model

Myeloid -specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model

Contents

Support

Contact